ProSolus Pharmaceuticals, a Miami, Florida-headquartered development and manufacturing company for transdermal and trans-mucosal drug delivery products, has expanded its manufacturing capabilities for trandsdermal drug delivery. ProSolus is a wholly owned subsidiary of Mission Pharmacal, a San Antonio, Texas-based pharmaceutical company.

The expansion included the installation of a second transdermal production facility at Mission’s manufacturing site in Boerne, Texas. The Boerne location houses a larger production line than Prosolus’ two manufacturing facilities in Miami, and the expansion at Boerne more than doubles the company’s total transdermal product output. Combined, the capacity of the two locations is now more than 100 million patches annually.

Source: Mission Pharmacal